Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)

Clinical trial NCT02480608 · COMPLETED

Trial details

NCT number: NCT02480608
Sponsor: University of Leipzig
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Start date: 2004-04-01
Primary completion: 2011-08-01
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.